The DOI matches its Crossref record; 1,025 of the 1,025 references it cites were found in a registry or an index.
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Open accessAbstract
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [¶][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, MS, PharmD, AACC Biykem Bozkurt, MD, PhD, FACC,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 1,001–1,025 of 1,025
Implantable defibrillators versus medical therapy for cardiac channelopathies
McNamara, D. A., Goldberger, J. J., Berendsen, M. A., & Huffman, M. D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011168.pub2 · Cited by 19
Stan, M. N., Sathananthan, M., Warnes, C. A., Brennan, M. D., Thapa, P., & Bahn, R. S. (2014) · Endocrine Practice · doi:10.4158/ep13059.or · Cited by 18
Kamioka, M., Mathew, S., Lin, T., Metzner, A., Rillig, A., Deiß, S., Rausch, P., Lemeš, C., Makimoto, H., Hu, H., et al. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0817-4 · Cited by 18
Verapamil-sensitive Ventricular Tachycardia in an Infant
Snyder, C. S., Bishara, J. A., Darling, R., & Lucas, V. S. (2006) · Congenital Heart Disease · doi:10.1111/j.1747-0803.2006.00020.x · Cited by 18
Kl, D., Adlakha, A., & Phillip, P. J. (1987) · PubMed · Cited by 18
Iqbal, J., Fay, R., Adlam, D., Squire, I. B., Parviz, Y., Gunn, J. P., Pitt, B., & Zannad, F. M. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.88 · Cited by 17
Proclemer, A., Ghidina, M., Facchin, D., Rebellato, L., Corrado, D., Gasparini, M., & Gregori, D. (2009) · Pacing and clinical electrophysiology : PACE · doi:10.1111/j.1540-8159.2009.02302.x · Cited by 17
Monasterio, V., Martínez, J. P., Laguna, P., McNitt, S. A., Polonsky, S., Moss, A. J., Haigney, M. C., Zaręba, W., & Couderc, J. (2013) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2013.08.004 · Cited by 15
Use of a Cardioselective Beta-Blocker for Pediatric Patients With Prolonged QT Syndrome
Moltedo, J. M., Kim, J. J., Friedman, R. A., Kertesz, N. J., & Cannon, B. C. (2010) · Pediatric Cardiology · doi:10.1007/s00246-010-9819-1 · Cited by 15
Frommeyer, G., Dechering, D. G., Kochhäuser, S., Bettin, M., Köbe, J., Eckardt, L., & Reinke, F. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0143-4 · Cited by 15
Improving Care of Out-of-Hospital Cardiac Arrest
Jollis, J. G., & Granger, C. B. (2016) · Circulation · doi:10.1161/circulationaha.116.025818 · Cited by 15
Self-citationCantero-Pérez, E. M., Sobrino‐Márquez, J. M., Grande‐Trillo, A., Lage-Gallé, E., Rangel‐Sousa, D., Ruiz, I. E., & Martínez-Martínez, Á. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.10.017 · Cited by 14
Surgical Options for Refractory Ventricular Tachycardia
Bhavani, S. S., TCHOU, P. J., Saliba, W., & Gillinov, A. M. (2007) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.2007.00468.x · Cited by 14
Hypertrophic Cardiomyopathy: One Gene … but Many Phenotypes
Maron, B. J., Haas, T. S., & Goodman, J. S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.02.032 · Cited by 14
Clinical and genetic features of Australian families with long QT syndrome: A registry‐based study
Burns, C., Ingles, J., Davis, A. M., et al. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.02.001 · Cited by 14
Fontan circulation over 30 years. What should we learn from those patients?
Sakamoto, T., Nagashima, M., Hiramatsu, T., Matsumura, G., Park, I., & Yamazaki, K. (2016) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492316667771 · Cited by 13
Gandjbakhch, E., Rovani, M., Varnous, S., Maupain, C., Chastre, T., Waintraub, X., Pousset, F., Lebreton, G., Duthoit, G., Badenco, N., et al. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.02.005 · Cited by 10
Predictors of sudden cardiac death in hypertrophic cardiomyopathy
槙, 早. (1999) · Medical Entomology and Zoology · Cited by 10
The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths
Tzimas, I., Zingraf, J.-C., Bajanowski, T., & Poetsch, M. (2016) · International Journal of Legal Medicine · doi:10.1007/s00414-016-1424-2 · Cited by 9
Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death.
Saeed, M., Homoud, M. K., Pj, W., et al. (2001) · PubMed · Cited by 7
Camm, C. F., & Camm, A. J. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12302 · Cited by 6
Determination of time since death from a study of various postmortem changes.
Chandra, J., & Sabharwal, K. (1968) · PubMed · Cited by 6
Rodbard, S., & Margolis, J. (1956) · Circulation · doi:10.1161/01.cir.13.4.510 · Cited by 5
Zhou, H.-Z., Karliner, J. S., Zhu, P., Mochly‐Rosen, D., Messing, R. O., & Gray, M. O. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)81343-2 · Cited by 2
Highlights of the year in JACC2004
DeMaria, A. N., Ben‐Yehuda, O., Berman, D. S., Feld, G. K., Greenberg, B., Knoke, J. D., Knowlton, K. U., Lew, W. Y. W., Narula, J., Sahn, D. J., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.015 · Cited by 2
Research works printed but not linked: 286
- Priori, 2016, G Ital Cardiol (Rome), 17, 108
- Link, 2015, Circulation, 132, e334
- Tabereaux, 2009, Mechanisms of VF maintenance: wandering wavelets, mother rotors, or foci, Heart Rhythm, 6, 405, 10.1016/j.hrthm.2008.11.005 · doi:10.1016/j.hrthm.2008.11.005
- Zhang, 2016, Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI, Pacing Clin Electrophysiol, 39, 781, 10.1111/pace.12882 · doi:10.1111/pace.12882
- Myerburg, 2015, Cardiac arrest and sudden cardiac death - Chapter 39, 821
- Noda, 2005, Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract, J Am Coll Cardiol, 46, 1288, 10.1016/j.jacc.2005.05.077 · DOI · Paper page
- Viskin, 2005, The “short-coupled” variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?, J Cardiovasc Electrophysiol, 16, 912, 10.1111/j.1540-8167.2005.50040.x · DOI · Paper page
- Nordhues, 2016, Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death, J Cardiovasc Electrophysiol, 27, 463, 10.1111/jce.12914 · doi:10.1111/jce.12914
- Linzer, 1990, Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope, Am J Cardiol, 66, 214, 10.1016/0002-9149(90)90591-N · DOI · Paper page
- Turakhia, 2013, Diagnostic utility of a novel leadless arrhythmia monitoring device, Am J Cardiol, 112, 520, 10.1016/j.amjcard.2013.04.017 · DOI · Paper page
- Dintzis, 1991, Genetic variation and the meiotic process, Res Publ Assoc Res Nerv Ment Dis, 69, 39
- Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
- Laedtke, 2012, Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA), J Genet Couns, 21, 345, 10.1007/s10897-011-9405-6 · DOI
- Costantini, 2009, The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention, J Am Coll Cardiol, 53, 471, 10.1016/j.jacc.2008.08.077 · DOI · Paper page
- Walker, 2005, Burst bicycle exercise facilitates diagnosis of latent long QT syndrome, Am Heart J, 150, 1059, 10.1016/j.ahj.2005.02.041 · doi:10.1016/j.ahj.2005.02.041
- Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
- Zareba, 2017, Ranolazine in High-Risk ICD Patients (RAID) Trial, Presented at: Heart Rhythm Society Annual Scientific Sessions
- Hirsowitz, 1986, The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia, Am Heart J, 111, 852, 10.1016/0002-8703(86)90633-2 · doi:10.1016/0002-8703(86)90633-2
- Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 · DOI · Paper page
- Rauch, 2010, OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction, Circulation, 122, 2152, 10.1161/CIRCULATIONAHA.110.948562 · DOI · Paper page
- Yancy, 2016, J Am Coll Cardiol, 68, 1476, 10.1016/j.jacc.2016.05.011 · DOI · Paper page
- 1999, The cardiac insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 · DOI · Paper page
- Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
- Dumas, 2016, Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry, J Am Coll Cardiol Intv, 9, 1011, 10.1016/j.jcin.2016.02.001 · DOI · Paper page
- Ngaage, 2008, Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia, Ann Thorac Surg, 85, 1278, 10.1016/j.athoracsur.2007.12.035 · doi:10.1016/j.athoracsur.2007.12.035
- Layser, 2016, Anomalous coronary arteries: analysis of clinical outcome based upon arterial course and surgical intervention in an adult population, Acad Radiol, 23, 1015, 10.1016/j.acra.2016.03.020 · doi:10.1016/j.acra.2016.03.020
- Krittayaphong, 2002, Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study, Am Heart J, 144, e10, 10.1067/mhj.2002.125516 · DOI
- Dorian, 2002, Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation, N Engl J Med, 346, 884, 10.1056/NEJMoa013029 · DOI · Paper page
- Kudenchuk, 2016, Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest, N Engl J Med, 1711, 10.1056/NEJMoa1514204 · DOI · Paper page
- Kudenchuk, 1999, Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation, N Engl J Med, 341, 871, 10.1056/NEJM199909163411203 · DOI · Paper page
- Spaulding, 1997, Immediate coronary angiography in survivors of out-of-hospital cardiac arrest, N Engl J Med, 336, 1629, 10.1056/NEJM199706053362302 · DOI · Paper page
- Cronier, 2011, Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation, Crit Care, 15, 10.1186/cc10227 · DOI
- Zanuttini, 2012, Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest, Am J Cardiol, 110, 1723, 10.1016/j.amjcard.2012.08.006 · DOI
- Dumas, 2016, Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry, J Am Coll Cardiol Intv, 9, 1011, 10.1016/j.jcin.2016.02.001 · DOI · Paper page
- Nademanee, 2000, Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy, Circulation, 102, 742, 10.1161/01.CIR.102.7.742 · DOI · Paper page
- Belhassen, 1984, Use of intravenous verapamil for ventricular tachycardia, Am J Cardiol, 54, 1131, 10.1016/S0002-9149(84)80158-7 · DOI
- Buxton, 1987, Hazards of intravenous verapamil for sustained ventricular tachycardia, Am J Cardiol, 59, 1107, 10.1016/0002-9149(87)90857-5 · DOI
- Zipes, 2006, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010 · DOI · Paper page
- Perkins, 2015, Circulation, 132, 1286, 10.1161/CIR.0000000000000144 · DOI · Paper page
- Link, 2015, Circulation, 132, e334
- Joglar, 2016, Out-of-hospital cardiac arrest–are drugs ever the answer?, N Engl J Med, 374, 1781, 10.1056/NEJMe1602790 · doi:10.1056/nejme1602790
- 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
- Connolly, 2000, Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study, Eur Heart J, 21, 2071, 10.1053/euhj.2000.2476 · DOI · Paper page
- Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016 · DOI · Paper page
- Morikawa, 2010, Letter by Morikawa et al regarding article, “coronary artery spasm: a 2009 update”, Circulation, 121, e16, 10.1161/CIR.0b013e3181ce1bcc · doi:10.1161/cir.0b013e3181ce1bcc
- Ascione, 2004, Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study, J Am Coll Cardiol, 43, 1630, 10.1016/j.jacc.2003.11.056 · DOI
- Saxon, 1995, Monomorphic versus polymorphic ventricular tachycardia after coronary artery bypass grafting, Am J Cardiol, 75, 403, 10.1016/S0002-9149(99)80566-9 · doi:10.1016/s0002-9149(99)80566-9
- Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 · DOI · Paper page
- Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
- Moss, 1996, Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med, 335, 1933, 10.1056/NEJM199612263352601 · DOI · Paper page
- Owens, 2002, Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator, Am Heart J, 144, 440, 10.1067/mhj.2002.125501 · DOI
- Buxton, 1999, A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 341, 1882, 10.1056/NEJM199912163412503 · DOI · Paper page
- Buxton, 2006, ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards, J Am Coll Cardiol, 48, 2360, 10.1016/j.jacc.2006.09.020 · DOI · Paper page
- Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016 · DOI · Paper page
- Buxton, 2000, Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 342, 1937, 10.1056/NEJM200006293422602 · DOI · Paper page
- Kusumoto, 2014, HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials, J Am Coll Cardiol, 64, 1143, 10.1016/j.jacc.2014.04.008 · DOI · Paper page
- Sapp, 2016, Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs, N Engl J Med, 375, 111, 10.1056/NEJMoa1513614 · DOI · Paper page
- Echt, 1991, Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial, N Engl J Med, 324, 781, 10.1056/NEJM199103213241201 · DOI · Paper page
- Steinberg, 1999, New-onset sustained ventricular tachycardia after cardiac surgery, Circulation, 99, 903, 10.1161/01.CIR.99.7.903 · DOI
- Claro, 2015, Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death, Cochrane Database Syst Rev, 12
- Bunch, 2011, Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks, Pacing Clin Electrophysiol, 34, 1600, 10.1111/j.1540-8159.2011.03208.x · DOI · Paper page
- 1992, Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators, N Engl J Med, 327, 227, 10.1056/NEJM199207233270403 · DOI · Paper page
- Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 · DOI · Paper page
- Berntsen, 1993, Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia, Eur Heart J, 14, 1297, 10.1093/eurheartj/14.10.1297 · doi:10.1093/eurheartj/14.10.1297
- Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, J Am Coll Cardiol Img, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
- Piers, 2013, Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy, Circ Arrhythm Electrophysiol, 6, 875, 10.1161/CIRCEP.113.000537 · DOI · Paper page
- Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, 13, 1077, 10.1093/europace/eur245 · DOI · Paper page
- Coleman, 2016, Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis, J Am Coll Cardiol Img
- 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
- Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 · DOI · Paper page
- Raitt, 2001, “Stable” ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics versus Implantable Defibrillators (AVID) registry, Circulation, 103, 244, 10.1161/01.CIR.103.2.244 · DOI
- Middlekauff, 1993, Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope, J Am Coll Cardiol, 21, 110, 10.1016/0735-1097(93)90724-F · DOI · Paper page
- Claro, 2015, Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death, Cochrane Database Syst Rev, 12
- Gatzoulis, 2013, Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation, Circ Arrhythm Electrophysiol, 6, 504, 10.1161/CIRCEP.113.000216 · DOI
- Hilfiker, 2015, Utility of electrophysiological studies to predict arrhythmic events, World J Cardiol, 7, 344, 10.4330/wjc.v7.i6.344 · DOI
- Thomas, 2008, Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality, Am Heart J, 155, 87, 10.1016/j.ahj.2007.09.010 · DOI
- Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 · DOI · Paper page
- Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 · DOI · Paper page
- Desai, 2004, Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials, JAMA, 292, 2874, 10.1001/jama.292.23.2874 · DOI · Paper page
- Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
- Anselme, 2013, Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders, Heart Rhythm, 10, 1492, 10.1016/j.hrthm.2013.06.020 · DOI
- Pasotti, 2008, Long-term outcome and risk stratification in dilated cardiolaminopathies, J Am Coll Cardiol, 52, 1250, 10.1016/j.jacc.2008.06.044 · DOI · Paper page
- Van Berlo, 2005, Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?, J Mol Med, 83, 79, 10.1007/s00109-004-0589-1 · DOI · Paper page
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Connolly, 2006, Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial, JAMA, 295, 165, 10.1001/jama.295.2.165 · DOI · Paper page
- Tung, 2015, Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study, Heart Rhythm, 12, 1997, 10.1016/j.hrthm.2015.05.036 · DOI · Paper page
- Piers, 2013, Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy, Circ Arrhythm Electrophysiol, 6, 875, 10.1161/CIRCEP.113.000537 · DOI · Paper page
- Groeneweg, 2015, Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members, Circ Cardiovasc Genet, 8, 437, 10.1161/CIRCGENETICS.114.001003 · DOI · Paper page
- Marcus, 2013, Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians, J Am Coll Cardiol, 61, 1945, 10.1016/j.jacc.2013.01.073 · DOI · Paper page
- Quarta, 2011, Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria, Circulation, 123, 2701, 10.1161/CIRCULATIONAHA.110.976936 · DOI · Paper page
- Hershberger, 2009, Genetic evaluation of cardiomyopathy–a Heart Failure Society of America practice guideline, J Card Fail, 15, 83, 10.1016/j.cardfail.2009.01.006 · DOI · Paper page
- Rigato, 2013, Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy, Circ Cardiovasc Genet, 6, 533, 10.1161/CIRCGENETICS.113.000288 · DOI · Paper page
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Christiaans, 2009, Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective, Am J Med Genet, 149a, 1444, 10.1002/ajmg.a.32915 · DOI
- Hamang, 2012, Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up, J Genet Counsel, 21, 72, 10.1007/s10897-011-9393-6 · DOI
- Zhu, 1998, The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy, Pacing Clin Electrophysiol, 21, 299, 10.1111/j.1540-8159.1998.tb01109.x · DOI
- Gersh, 2011, J Am Coll Cardiol, 58, e212, 10.1016/j.jacc.2011.06.011 · DOI · Paper page
- Saeed, 2001, Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death, J Invasive Cardiol, 13, 758
- Winkel, 2002, Myocarditis. Curr Treat Options, Cardiovasc Med, 4, 455
- Huang, 2013, Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythematosus, Rheumatol Int, 33, 1093, 10.1007/s00296-011-2240-0 · doi:10.1007/s00296-011-2240-0
- Muratore, 1997, Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?, Pacing Clin Electrophysiol, 20, 194, 10.1111/j.1540-8159.1997.tb04841.x · doi:10.1111/j.1540-8159.1997.tb04841.x
- d'Avila, 2002, New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas' disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas' VT, J Interv Card Electrophysiol, 7, 23, 10.1023/A:1020811915133 · doi:10.1023/a:1020811915133
- Coleman, 2016, Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis, J Am Coll Cardiol Img, 10, 411, 10.1016/j.jcmg.2016.05.009 · DOI · Paper page
- Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, J Am Coll Cardiol Img, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
- Naruse, 2014, Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis, Circ Arrhythm Electrophysiol, 7, 407, 10.1161/CIRCEP.113.000734 · DOI
- Birnie, 2014, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis, Heart Rhythm, 11, 1305, 10.1016/j.hrthm.2014.03.043 · DOI · Paper page
- Frohlich, 2013, Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation, Heart, 99, 1158, 10.1136/heartjnl-2013-304185 · DOI
- Kao, 2012, Wearable defibrillator use in heart failure (WIF): results of a prospective registry, BMC Cardiovasc Disord, 12, 123, 10.1186/1471-2261-12-123 · DOI
- Vakil, 2017, Impact of implantable cardioverter-defibrillators on waitlist mortality among patients awaiting heart transplantation. An UNOS/OPTN Analysis, JACC Clin Electrophysiol, 3, 33, 10.1016/j.jacep.2016.07.010 · DOI
- 1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 · DOI · Paper page
- Pitt, 2003, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207 · DOI · Paper page
- Desai, 2015, Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients, Eur Heart J, 36, 1990, 10.1093/eurheartj/ehv186 · DOI · Paper page
- Vakil, 2016, Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis, JACC Heart Fail, 4, 772, 10.1016/j.jchf.2016.05.003 · DOI
- Cantillon, 2010, Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator, Heart Rhythm, 7, 466, 10.1016/j.hrthm.2009.12.022 · doi:10.1016/j.hrthm.2009.12.022
- Slaughter, 2011, Destination therapy with left ventricular assist devices: patient selection and outcomes, Curr Opin Cardiol, 26, 232, 10.1097/HCO.0b013e328345aff4 · doi:10.1097/hco.0b013e328345aff4
- Anselme, 2013, Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders, Heart Rhythm, 10, 1492, 10.1016/j.hrthm.2013.06.020 · DOI
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Meune, 2006, Primary prevention of sudden death in patients with lamin A/C gene mutations, N Engl J Med, 354, 209, 10.1056/NEJMc052632 · DOI · Paper page
- Pasotti, 2008, Long-term outcome and risk stratification in dilated cardiolaminopathies, J Am Coll Cardiol, 52, 1250, 10.1016/j.jacc.2008.06.044 · DOI · Paper page
- Van Berlo, 2005, Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?, J Mol Med, 83, 79, 10.1007/s00109-004-0589-1 · DOI · Paper page
- Epstein, 2008, J Am Coll Cardiol, 51, e1, 10.1016/j.jacc.2008.02.032 · DOI · Paper page
- Kumar, 2016, Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers, J Am Coll Cardiol, 68, 2299, 10.1016/j.jacc.2016.08.058 · DOI · Paper page
- Goldenberg, 2011, Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals, J Am Coll Cardiol, 57, 51, 10.1016/j.jacc.2010.07.038 · DOI · Paper page
- Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
- Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 · DOI · Paper page
- Wedekind, 2009, QT interval prolongation and risk for cardiac events in genotyped LQTS-index children, Eur J Pediatr, 168, 1107, 10.1007/s00431-008-0896-6 · DOI
- Kaufman, 2008, Risk of death in the long QT syndrome when a sibling has died, Heart Rhythm, 5, 831, 10.1016/j.hrthm.2008.02.029 · DOI
- Kimbrough, 2001, Clinical implications for affected parents and siblings of probands with long-QT syndrome, Circulation, 104, 557, 10.1161/hc3001.093501 · DOI
- Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, JAMA, 296, 1249, 10.1001/jama.296.10.1249 · DOI · Paper page
- Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 · DOI · Paper page
- Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
- Paludan-Muller, 2017, Integration of 60,000 exomes and ACMG guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants, Clin Genet, 91, 63, 10.1111/cge.12847 · DOI
- Giustetto, 2011, Long-term follow-up of patients with short QT syndrome, J Am Coll Cardiol, 58, 587, 10.1016/j.jacc.2011.03.038 · DOI · Paper page
- Mahida, 2015, Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome, J Am Coll Cardiol, 65, 151, 10.1016/j.jacc.2014.10.043 · DOI
- Mazzanti, 2014, Novel insight into the natural history of short QT syndrome, J Am Coll Cardiol, 63, 1300, 10.1016/j.jacc.2013.09.078 · DOI · Paper page
- Rodriguez-Manero, 2016, Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study, Heart Rhythm, 13, 669, 10.1016/j.hrthm.2015.10.038 · DOI
- Moss, 2000, Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome, Circulation, 101, 616, 10.1161/01.CIR.101.6.616 · DOI · Paper page
- Vincent, 2009, High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”, Circulation, 119, 215, 10.1161/CIRCULATIONAHA.108.772533 · DOI · Paper page
- Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, JAMA, 296, 1249, 10.1001/jama.296.10.1249 · DOI · Paper page
- Mazzanti, 2016, Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3, J Am Coll Cardiol, 67, 1053, 10.1016/j.jacc.2015.12.033 · DOI · Paper page
- Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
- Wedekind, 2009, QT interval prolongation and risk for cardiac events in genotyped LQTS-index children, Eur J Pediatr, 168, 1107, 10.1007/s00431-008-0896-6 · DOI
- Hofferberth, 2014, Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc, Surg, 147, 404
- Bai, 2009, Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing, Circ Arrhythm Electrophysiol, 2, 6, 10.1161/CIRCEP.108.782888 · DOI
- Costa, 2012, Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome, Heart Rhythm, 9, 892, 10.1016/j.hrthm.2012.01.020 · DOI
- Kim, 2010, Trigger-specific risk factors and response to therapy in long QT syndrome type 2, Heart Rhythm, 7, 1797, 10.1016/j.hrthm.2010.09.011 · DOI
- Migdalovich, 2011, Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome, Heart Rhythm, 8, 1537, 10.1016/j.hrthm.2011.03.049 · DOI
- Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 · DOI · Paper page
- Goldenberg, 2011, Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals, J Am Coll Cardiol, 57, 51, 10.1016/j.jacc.2010.07.038 · DOI · Paper page
- Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
- Wilde, 2016, Clinical aspects of type 3 long-QT syndrome: an international multicenter study, Circulation, 134, 872, 10.1161/CIRCULATIONAHA.116.021823 · DOI · Paper page
- Garson, 1993, The long QT syndrome in children. An international study of 287 patients, Circulation, 87, 1866, 10.1161/01.CIR.87.6.1866 · DOI · Paper page
- Dorostkar, 1999, Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing, Circulation, 100, 2431, 10.1161/01.CIR.100.24.2431 · DOI
- Eldar, 1992, Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome, J Am Coll Cardiol, 20, 830, 10.1016/0735-1097(92)90180-U · DOI
- Moss, 1991, Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome, Circulation, 84, 1524, 10.1161/01.CIR.84.4.1524 · DOI · Paper page
- Bos, 2013, Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders, Circ Arrhythm Electrophysiol, 6, 705, 10.1161/CIRCEP.113.000102 · doi:10.1161/circep.113.000102
- Li, 2008, Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome, Ann Thorac Surg, 86, 1955, 10.1016/j.athoracsur.2008.07.100 · doi:10.1016/j.athoracsur.2008.07.100
- Zhang, 2015, Identification of low-risk adult congenital LQTS patients, J Cardiovasc Electrophysiol, 26, 853, 10.1111/jce.12686 · doi:10.1111/jce.12686
- Spazzolini, 2009, Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy, J Am Coll Cardiol, 54, 832, 10.1016/j.jacc.2009.05.029 · DOI
- Hayashi, 2009, Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia, Circulation, 119, 2426, 10.1161/CIRCULATIONAHA.108.829267 · DOI · Paper page
- Collura, 2009, Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery, Heart Rhythm, 6, 752, 10.1016/j.hrthm.2009.03.024 · DOI · Paper page
- Schneider, 2013, Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome, Clin Res Cardiol, 102, 33, 10.1007/s00392-012-0492-7 · DOI
- Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 · DOI · Paper page
- Adler, 2016, Patient outcomes from a specialized inherited arrhythmia clinic, Circ Arrhythm Electrophysiol, 9, e003440, 10.1161/CIRCEP.115.003440 · DOI
- Olde Nordkamp, 2016, Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications, Heart Rhythm, 13, 443, 10.1016/j.hrthm.2015.09.010 · DOI · Paper page
- De Ferrari, 2015, Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation, Circulation, 131, 2185, 10.1161/CIRCULATIONAHA.115.015731 · DOI · Paper page
- Wilde, 2008, Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia, N Engl J Med, 358, 2024, 10.1056/NEJMoa0708006 · DOI · Paper page
- Zhang, 2015, Long-QT syndrome and therapy for attention deficit/hyperactivity disorder, J Cardiovasc Electrophysiol, 26, 1039, 10.1111/jce.12739 · DOI
- Jabbari, 2013, New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia, Circ Cardiovasc Genetics, 6, 481, 10.1161/CIRCGENETICS.113.000118 · DOI
- Paludan-Muller, 2017, Integration of 60,000 exomes and acmg guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants, Clin Genet, 91, 63, 10.1111/cge.12847 · DOI
- Gehi, 2006, Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis, J Cardiovasc Electrophysiol, 17, 577, 10.1111/j.1540-8167.2006.00455.x · DOI · Paper page
- Hiraoka, 2013, Prognosis and risk stratification of young adults with Brugada syndrome, J Electrocardiol, 46, 279, 10.1016/j.jelectrocard.2013.04.003 · DOI
- Priori, 2012, Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry, J Am Coll Cardiol, 59, 37, 10.1016/j.jacc.2011.08.064 · DOI · Paper page
- Probst, 2010, Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry, Circulation, 121, 635, 10.1161/CIRCULATIONAHA.109.887026 · DOI · Paper page
- Delise, 2011, Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach, Eur Heart J, 32, 169, 10.1093/eurheartj/ehq381 · DOI · Paper page
- Kusumoto, 2018, J Am Coll Cardiol, 72, 1653, 10.1016/j.jacc.2017.10.052 · DOI
- Crotti, 2012, Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing, J Am Coll Cardiol, 60, 1410, 10.1016/j.jacc.2012.04.037 · DOI · Paper page
- Probst, 2009, SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome, Circ Cardiovasc Genet, 2, 552, 10.1161/CIRCGENETICS.109.853374 · DOI · Paper page
- Risgaard, 2013, High prevalence of genetic variants previously associated with Brugada syndrome in new exome data, Clinical Genetics, 84, 489, 10.1111/cge.12126 · DOI
- Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
- Rodriguez-Manero, 2016, Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study, Heart Rhythm, 13, 669, 10.1016/j.hrthm.2015.10.038 · DOI
- Conte, 2015, Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience, J Am Coll Cardiol, 65, 879, 10.1016/j.jacc.2014.12.031 · DOI · Paper page
- Priori, 2002, Natural history of Brugada syndrome: insights for risk stratification and management, Circulation, 105, 1342, 10.1161/hc1102.105288 · DOI · Paper page
- Siebermair, 2016, Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years, Europace, 18, 718, 10.1093/europace/euv301 · DOI
- Giustetto, 2011, Long-term follow-up of patients with short QT syndrome, J Am Coll Cardiol, 58, 587, 10.1016/j.jacc.2011.03.038 · DOI · Paper page
- Mazzanti, 2014, Novel insight into the natural history of short QT syndrome, J Am Coll Cardiol, 63, 1300, 10.1016/j.jacc.2013.09.078 · DOI · Paper page
- Giustetto, 2006, Short QT syndrome: clinical findings and diagnostic-therapeutic implications, Eur Heart J, 27, 2440, 10.1093/eurheartj/ehl185 · DOI · Paper page
- Iribarren, 2014, Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis, Ann Noninvasive Electrocardiol, 19, 490, 10.1111/anec.12157 · DOI
- Gollob, 2011, Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper, Can J Cardiol, 27, 232, 10.1016/j.cjca.2010.12.078 · DOI
- Gill, 1993, Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology, Am Heart J, 126, 1126, 10.1016/0002-8703(93)90664-U · DOI
- Gill, 1992, Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia, Pacing Clin Electrophysiol, 15, 2122, 10.1111/j.1540-8159.1992.tb03033.x · DOI
- Kontos, 2011, Treatment and outcomes in patients with myocardial infarction treated with acute beta–blocker therapy: results from the American College of Cardiology's NCDR(R), Am Heart J, 161, 864, 10.1016/j.ahj.2011.01.006 · DOI
- Levine, 1996, Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group, J Am Coll Cardiol, 27, 67, 10.1016/0735-1097(95)00427-0 · DOI · Paper page
- Noda, 2005, Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract, J Am Coll Cardiol, 46, 1288, 10.1016/j.jacc.2005.05.077 · DOI · Paper page
- Viskin, 2005, The “short-coupled” variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?, J Cardiovasc Electrophysiol, 16, 912, 10.1111/j.1540-8167.2005.50040.x · DOI · Paper page
- Krittayaphong, 2002, Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study, Am Heart J, 144, e10, 10.1067/mhj.2002.125516 · DOI
- Ling, 2014, Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study, Circ Arrhythm Electrophysiol, 7, 237, 10.1161/CIRCEP.113.000805 · DOI · Paper page
- Badhwar, 2007, Idiopathic ventricular tachycardia: diagnosis and management, Curr Probl Cardiol, 32, 7, 10.1016/j.cpcardiol.2006.10.002 · DOI
- Connolly, 1999, Meta-analysis of antiarrhythmic drug trials, Am J Cardiol, 84, 90R, 10.1016/S0002-9149(99)00708-0 · DOI
- Ling, 2014, Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study, Circ Arrhythm Electrophysiol, 7, 237, 10.1161/CIRCEP.113.000805 · DOI · Paper page
200 of 286 shown
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citation2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Attia, Z. I., Kapa, S., Lopez-Jimenez, F., McKie, P. M., Ladewig, D. J., Satam, G., Pellikka, P. A., Enriquez-Sarano, M., Noseworthy, P. A., Munger, T. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0240-2 · Cited by 1,389
Metadata
- Authors
- Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., Gillis, A. M., Granger, C. B., Hammill, S. C., Hlatky, M. A., Joglar, J. A., Kay, G. N., Matlock, D. D., Myerburg, R. J., & Page, R. L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 72
- Issue
- 14
- Pages
- e91-e220
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2940793653
- Cited by
- 1,854
- References
- 1,025
- FWCI
- 144.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-10-02)
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.